TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005
TCL Archive An “insurgency” targets randomized trials, demands access to investigational drugs. August 5, 2005